XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Series D Preferred Stock
Series E Preferred Stock
Common Stock
Total Stockholders’ Equity
Total Stockholders’ Equity
Series A Preferred Stock
Total Stockholders’ Equity
Series B Preferred Stock
Total Stockholders’ Equity
Series D Preferred Stock
Total Stockholders’ Equity
Series E Preferred Stock
Total Stockholders’ Equity
Common Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series D Preferred Stock
Preferred Stock
Series E Preferred Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Common Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Accumulated Deficit
Series A Preferred Stock
Accumulated Deficit
Series B Preferred Stock
Accumulated Deficit
Series D Preferred Stock
Accumulated Deficit
Series E Preferred Stock
Non-controlling interest
Beginning balance (in shares) at Dec. 31, 2022                         6,799,467 4,695,887       104,141,899                  
Beginning balance at Dec. 31, 2022 $ 1,453,919           $ 1,439,021           $ 68 $ 47       $ 2,371 $ 2,683,169   $ 1,147 $ (1,247,781)         $ 14,898
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Common stock issuance costs           $ (21)           $ (21)               $ (21)              
Dividends declared, common stock (41,677)           (41,677)                             (41,677)          
Dividends declared, preferred stock   $ (3,081) $ (2,018)         $ (3,081) $ (2,018)                           $ (3,081) $ (2,018)      
Equity-based compensation, net of forfeitures (in shares)                                 16,011                    
Equity-based compensation, net of forfeitures 2,925           679                       679               2,246
Common stock shares withheld upon vesting of restricted stock 0                                                    
Distributions to non-controlling interest holders (100)           (100)                             (100)         0
Net loss (890)           (890)                             (890)          
Cumulative translation adjustment 6,520           6,520                           6,520            
Designated derivatives, fair value adjustments (3,965)           (3,965)                           (3,965)            
Ending balance (in shares) at Mar. 31, 2023                         6,799,467 4,695,887       104,157,910                  
Ending balance at Mar. 31, 2023 1,411,612           1,394,468           $ 68 $ 47       $ 2,371 2,683,827   3,702 (1,295,547)         17,144
Beginning balance (in shares) at Dec. 31, 2023                         6,799,467 4,695,887 7,933,711 4,595,175   230,885,197                  
Beginning balance at Dec. 31, 2023 2,639,149           2,637,752           $ 68 $ 47 $ 79 $ 46   $ 3,639 4,350,112   (14,096) (1,702,143)         1,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Dividends declared, common stock (81,923)           (81,923)                             (81,923)          
Dividends declared, preferred stock   $ (3,081) $ (2,018) $ (3,719) $ (2,118)     $ (3,081) $ (2,018) $ (3,719) $ (2,118)                       $ (3,081) $ (2,018) $ (3,719) $ (2,118)  
Equity-based compensation, net of forfeitures (in shares)                                 (33,678)                    
Equity-based compensation, net of forfeitures 1,973           1,520                   $ 0   1,520               453
Common stock shares withheld upon vesting of restricted stock (in shares)                                 (4,948)                    
Common stock shares withheld upon vesting of restricted stock (55)           (55)                   $ 0   (55)                
Distributions to non-controlling interest holders (41)                                                   (41)
Net loss (23,751)           (23,751)                             (23,751)          
Cumulative translation adjustment (974)           (974)                           (974)            
Designated derivatives, fair value adjustments 3,226           3,226                           3,226            
Ending balance (in shares) at Mar. 31, 2024                         6,799,467 4,695,887 7,933,711 4,595,175   230,846,571                  
Ending balance at Mar. 31, 2024 $ 2,526,668           $ 2,524,859           $ 68 $ 47 $ 79 $ 46   $ 3,639 $ 4,351,577   $ (11,844) $ (1,818,753)         $ 1,809